Assessment of serum levels of asymmetric dimethylarginine, symmetric dimethylarginine and l-arginine in coronary artery disease

By Gad Mohamed Z.   Hassanein Sally I.   Abdel-Maksoud Sahar M.   Shaban Gamal M.   Abou-Aisha Khaled   Elgabarty Hossam A.  

Biomarkers, Vol. 15, Iss. 8, 2010-12 ,pp. : 746-752

Informa Healthcare

Access to resources Recommend Favorite

Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1)

By Strobel Joachim   Müller Fabian   Zolk Oliver   Endreß Beate   König Jörg   Fromm Martin   Maas Renke  

Amino Acids, Vol. 45, Iss. 4, 2013-10 ,pp. : 989-1002

Springer Publishing Company

Access to resources Recommend Favorite

Changes of urinary phospholipids in the chronic kidney disease patients

By Yang Wen-Ling   Bai Qiong   Li Dan-Dan   A Ta-La   Wang Song   Zhao Rong-Sheng   Nie Hong-Gang   Zhang Ai-Hua   Wang Tao   Fan Min-Hua  

Biomarkers, Vol. 18, Iss. 7, 2013-11 ,pp. : 601-606

Informa Healthcare

Access to resources Recommend Favorite

Darbepoetin alfa: a new therapy for the management of anaemia associated with chronic kidney disease

By Lindberg Jill  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 8, 2002-12 ,pp. : 977-984

Informa Healthcare

Access to resources Recommend Favorite

Clinical and research markers of oxidative stress in chronic kidney disease

By Tucker Patrick Steven  

Biomarkers, Vol. 18, Iss. 2, 2013-03 ,pp. : 103-115

Informa Healthcare

Access to resources Recommend Favorite